Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.41B P/E 33.79 EPS this Y 1.10% Ern Qtrly Grth 111.00%
Income 427.2M Forward P/E 24.47 EPS next Y 25.10% 50D Avg Chg -3.00%
Sales 2.96B PEG 2.05 EPS past 5Y 18.36% 200D Avg Chg -1.00%
Dividend N/A Price/Book 8.82 EPS next 5Y 14.15% 52W High Chg -16.00%
Recommedations 2.00 Quick Ratio 0.93 Shares Outstanding 145.34M 52W Low Chg 47.00%
Insider Own 33.17% ROA 7.70% Shares Float 89.37M Beta 1.18
Inst Own 77.67% ROE 33.67% Shares Shorted/Prior 3.32M/4.38M Price 70.95
Gross Margin 51.25% Profit Margin 14.41% Avg. Volume 894,175 Target Price 88.40
Oper. Margin 16.06% Earnings Date May 2 Volume 1,979,176 Change 1.11%
About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bruker Corporation News
04/22/24 Bruker to Acquire the NanoString Business in an Asset Deal
04/18/24 Bruker to acquire Nanostring for $393M
04/09/24 Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
04/08/24 Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
04/08/24 Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
04/04/24 Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04/01/24 Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
03/22/24 Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
03/14/24 Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
03/14/24 Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
03/12/24 Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
03/11/24 Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
03/07/24 Bruker Announces Closing of Chemspeed Technologies AG Acquisition
03/06/24 Director Hermann Requardt Sells 15,000 Shares of Bruker Corp (BRKR)
03/05/24 Here's Why Investors Should Retain Bruker (BRKR) Stock Now
03/01/24 Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup
02/28/24 Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
02/26/24 Burkhard Prause Sells 15,319 Shares of Bruker Corp
02/26/24 Bruker Corp President & CEO Burkhard Prause Sells 15,319 Shares
02/26/24 Bruker's (BRKR) New Launches Drive Growth Amid FX Woes
BRKR Chatroom

User Image tradingtwenty Posted - 7 hours ago

Top 5 oversold stocks that have trended in the past 24 hours: $BYON 18.01🔥 $PWSC 19.00 $CPRI 19.22 $CRNC 20.55 $BRKR 23.96 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image Krzysiu Posted - 1 day ago

$NSTGQ The PR from $BRKR caught more attention. I am confident the sale proceeds cover all outstanding debts & fees. Ran through the figures multiple times and have seen others formulate a similar conclusion. I can't think of a good enough reason why NSTG management would want to keep their existing securities trading OTC. I anticipate shareholder compensation for shares from the residual proceeds, that would result in significant gain even at current share price.

User Image briefingcom Posted - 1 day ago

$BRKR: Bruker to acquire the NanoString Business in an asset deal https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240422070519BRKR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image tradingtwenty Posted - 1 day ago

Top 5 oversold stocks that have trended in the past 24 hours: $PLD 15.23🔥 $BYON 18.27 $PATH 21.87 $BRKR 22.67 $CTRN 23.12 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image DonCorleone77 Posted - 1 day ago

$BRKR Bruker to acquire NanoString in $329.6M asset deal, sees accretion Bruker announced that it has entered into a definitive acquisition agreement with NanoString Technologies, headquartered in Seattle, Washington, a provider of solutions for spatial transcriptomics and gene expression analysis. Under the asset purchase agreement, Bruker expects to acquire substantially all of the assets and rights associated with NanoString's business, including the nCounter, GeoMx, CosMx and AtoMx product lines, for approximately $392.6M in cash, and the assumption of certain liabilities. In 2023, NanoString generated revenues of approximately $168M. On April 19, the transaction was approved under a court-supervised Chapter 11 sale process pursuant to Section 363 of the U.S. Bankruptcy Code, and it is expected to close in the second quarter of 2024, subject to customary closing conditions. NanoString is a provider of life science tools for discovery and translational research with leading solutions for spatial transcriptomics and gene expression analysis. For over fifteen years, and with over 7,000 peer-reviewed publications, scientists and medical researchers have relied on NanoString's pioneering instruments to advance biological, translational and clinical disease research. Bruker expects to fund the acquisition with cash on hand and established debt instruments. Following the closing, the NanoString business will become part of the Bruker Spatial Biology business. Bruker is unable to provide guidance estimates for the NanoString business for the remainder of 2024, as its financial performance cannot yet be reliably estimated, given the disruption of the Chapter 11 reorganization, the previous European Unified Patent Court's injunction on CosMx sales, and the uncertainties of various U.S. and European IP and antitrust litigation proceedings against an unusually aggressive, larger spatial and single-cell biology competitor. As a preliminary estimate, for the remainder of 2024, the transaction is expected to be dilutive to non-GAAP EPS by 15c to 20c. By 2026, Bruker expects the NanoString business to have rebounded and to be near break-even with resumed revenue growth and margin improvements, also taking advantage of deal synergies, as Bruker is not acquiring NanoString's public company overhead in this asset deal.

User Image OpenOutcrier Posted - 1 day ago

$BRKR (+0.3% pre) Bruker to Acquire the NanoString Business in an Asset Deal - BW https://ooc.bz/l/30956

User Image Stock_Titan Posted - 1 day ago

$BRKR Bruker to Acquire the NanoString Business in an Asset Deal https://www.stocktitan.net/news/BRKR/bruker-to-acquire-the-nano-string-business-in-an-asset-twxghxyd4cfz.html

User Image DA87 Posted - 3 days ago

On 3/10 $NSTGQ issued a PR stating Patient Square Capital will take them private. What makes us think the $BRKR deal does not include the same?

User Image Jodah Posted - 5 days ago

$BRKR many bad acquisitions last one being chapter 11 company Nanostring. Are these guys nuts? Do they have any money left?

User Image tastee435 Posted - 5 days ago

$BRKR $NSTGQ https://www.businesswire.com/news/home/20240417235250/en/NanoString-Technologies-to-Be-Acquired-by-Bruker-Corporation

User Image putih Posted - 5 days ago

$NSTGQ Based on after hours action, the market reckons $BRKR has only increased in value by $145M. The management clearly knows otherwise, so I'm guessing there will be a price jump tomorrow morning.

User Image Stock_Titan Posted - 2 weeks ago

$BRKR Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies https://www.stocktitan.net/news/BRKR/bruker-advances-magnet-technology-for-broader-adoption-of-nmr-in-fphsibyo9x59.html

User Image Stock_Titan Posted - 2 weeks ago

$BRKR Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research https://www.stocktitan.net/news/BRKR/biognosys-and-alamar-biosciences-forge-strategic-partnership-in-s56h0ou3bjjt.html

User Image Stock_Titan Posted - 3 weeks ago

$BRKR Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook https://www.stocktitan.net/news/BRKR/bruker-selected-as-company-of-the-year-by-instrument-business-uo45mif3b6cf.html

User Image Jodah Posted - 03/28/24

$BRKR tanking post market? Why?

User Image BP138 Posted - 1 month ago

$BRKR What are we thinking?

User Image HI_WATCH_LIVIN_DE_LIFE Posted - 1 month ago

$BTC.X If Bitcoin has no value; WHY IS THE PRICE PUMPING before the halving? Uncle Warren just didn't get this one right. Is it that he sticks to what he knows and undermines what competes? $BRK.B $BRK.A $BRKR $KO

User Image Stock_Titan Posted - 1 month ago

$BRKR Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO https://www.stocktitan.net/news/BRKR/bruker-advances-ccs-enabled-4d-proteomics-tims-tof-solutions-for-dhov9cuof798.html

User Image Stock_Titan Posted - 1 month ago

$BRKR Bruker Announces Closing of Chemspeed Technologies AG Acquisition https://www.stocktitan.net/news/BRKR/bruker-announces-closing-of-chemspeed-technologies-ag-9nrlzr8113nv.html

User Image Manipulation13F Posted - 1 month ago

$BRKR 🍻

User Image swingingtech Posted - 1 month ago

$BRKR $CAH $SYK $DVA https://wallstreetwaves.com/heres-why-investors-should-retain-bruker-brkr-stock-now-2/

User Image Thestocktraderhubzee Posted - 1 month ago

$BRKR UBS Maintains Buy on Bruker, Raises Price Target to $102

User Image Stocktwits Posted - 1 month ago

$BRKR a must add to your watchlist ⌚

User Image ATMcharts Posted - 1 month ago

$BRKR let's go! we hold until everyone has these tools in their garage

User Image DonCorleone77 Posted - 1 month ago

$BRKR My dude @ATMcharts spoke about BRKR last week on the 'Momentum Monday' podcast: Bruker price target raised to $102 from $94 at UBS UBS raised the firm's price target on Bruker to $102 from $94 and keeps a Buy rating on the shares. Bruker remains a top pick and UBS views the company as well-positioned on 2024 guidance and the recent pull-forward of the 2026 targets to 2025, the analyst tells investors in a research note.

User Image Stock_Titan Posted - 02/28/24

$BRKR Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup https://www.stocktitan.net/news/BRKR/bruker-announces-share-purchase-agreement-to-acquire-molecular-5fu7ocghcelk.html

User Image TickerDD_com Posted - 02/26/24

From 2/23/2024, looking back across 22 Month-Ends for BRKR, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had More Positives (95%) $BRKR #BRKR #BRKRStock #TickerDD #BRKRPrice https://www.youtube.com/watch?v=3iFp1zO2g-0

User Image 50bps Posted - 02/26/24

$BRKR trim n trail

User Image swingingtech Posted - 02/26/24

$BRKR $CAH $DVA $PODD https://wallstreetwaves.com/brukers-brkr-new-launches-drive-growth-amid-fx-woes/

User Image Stock_Titan Posted - 02/26/24

$BRKR Bruker Corporation to Present at Upcoming Investor Conferences https://www.stocktitan.net/news/BRKR/bruker-corporation-to-present-at-upcoming-investor-rjecmrux900l.html

Analyst Ratings
Goldman Sachs Sell Apr 10, 24
UBS Buy Mar 1, 24
UBS Buy Feb 15, 24
Citigroup Buy Feb 14, 24
Stifel Hold Feb 14, 24
JP Morgan Overweight Feb 14, 24
Wells Fargo Equal-Weight Dec 19, 23
Wolfe Research Outperform Dec 13, 23
JP Morgan Neutral Oct 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LAUKIEN FRANK H PRESIDENT & CEO PRESIDENT & CEO Oct 26 Option 46.15 59,523 2,746,986 38,327,911 10/30/23
LAUKIEN FRANK H PRESIDENT & CEO PRESIDENT & CEO Aug 08 Sell 64.81 37,947 2,459,345 38,217,344 08/10/23
LAUKIEN FRANK H PRESIDENT & CEO PRESIDENT & CEO Aug 08 Option 47.85 44,150 2,112,578 38,255,291 08/10/23
LAUKIEN FRANK H PRESIDENT & CEO PRESIDENT & CEO May 03 Sell 79.21 16,435 1,301,816 38,352,034 05/04/23
Friend Cynthia M Director Director Jan 17 Sell 68.26 921 62,867 11,576 01/19/23
PACKER RICHARD A Director Director Dec 06 Option 17.75 20,000 355,000 79,907 12/07/22
PACKER RICHARD A Director Director Dec 06 Sell 66.18 20,000 1,323,600 59,907 12/07/22
LINTON WILLIAM A Director Director Dec 06 Option 16.42 10,000 164,200 21,078 12/07/22
LAUKIEN FRANK H PRESIDENT & CEO PRESIDENT & CEO May 11 Buy 57.6370 1,710 98,559 38,476,233 05/16/22